Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05065450 · ClinicalTrials.gov registry record · NA

Amygdala Memory Enhancement

A NA study of Traumatic Brain Injury and Epilepsy, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05065450 is a NA study of Traumatic Brain Injury and Epilepsy that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 90 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05065450, a NA study of Traumatic Brain Injury and Epilepsy, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The objective is to understand how amygdala activation affects other medial temporal lobe structures to prioritize long-term memories. The project is relevant to disorders of memory and to disorders involving affect and memory, including traumatic brain injury and post-traumatic stress disorder.

Interventions

  • DEVICE Intracranial Stimulation

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2021-11-01
Est. Completion 2027-11-01
Phase NA

What the Registry Record Tells You About NCT05065450

The ClinicalTrials.gov registry entry for NCT05065450 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (68% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Intracranial Stimulation is the first listed.

NCT05065450 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05065450 about?

NCT05065450 is a clinical study titled "Amygdala Memory Enhancement". The objective is to understand how amygdala activation affects other medial temporal lobe structures to prioritize long-term memories. The project is relevant to disorders of memory and to disorders involving affect and memory, including traumatic brain injury and post-traumatic stress disorder.

What is the current status of trial NCT05065450?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2021-11-01. Estimated completion is 2027-11-01.

What conditions does trial NCT05065450 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Epilepsy, Post Traumatic Stress Disorder, Cognitive Impairment, Brain Diseases.

What interventions are being tested in trial NCT05065450?

The interventions under investigation include: Intracranial Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05065450?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05065450 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.